The subscription period in Alligator Bioscience’s rights issue commences today
Today is the first day of the subscription period in Alligator Bioscience AB (publ)’s (“Alligator” or the “Company”) rights issue of shares which was resolved upon by the Board of Directors on December 15, 2020 pursuant to the authorization from the Annual General Meeting on May 5, 2020 (the "Rights Issue"). The general public also has the opportunity to subscribe for shares in the Rights Issue.To ensure continued successful development in accordance with the Company's business plan and strategy, the Board of Directors of Alligator has resolved to carry out the Rights Issue of approximately